Featured image of the article "Q1 2023 Therapeutic mRNA Patent Monitor Report: Uncovering Current Dynamics in mRNA Design & Delivery".

Q1 2023 Therapeutic mRNA Patent Monitor Report: Uncovering Current Dynamics in mRNA Design & Delivery

SOPHIA ANTIPOLIS, France – April 21, 2023 │ The quarterly report for the Q1 2023 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. Let’s focus on current dynamics in mRNA design & delivery. Q1 2023: Exploring the dynamic activity of[…]

Featured image of article Therapeutic mRNA – Delivery is still of major interest.

Therapeutic mRNA – Delivery is still of major interest

SOPHIA ANTIPOLIS, France – March 22, 2023 │The Quarterly Report for the Q4 2022 Therapeutic mRNA Patent Monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. Let’s focus on one of the most dynamic segments. KnowMade has developed expertise in the field of therapeutic[…]

Featured image of article Are there specific memory technologies claimed in patents that are more suitable than others for artificial intelligence/machine learning (AI/ML) applications?

Are there specific memory technologies claimed in patents that are more suitable than others for artificial intelligence/machine learning (AI/ML) applications?

SOPHIA ANTIPOLIS, France – February 24, 2023 │ KnowMade releases a new report to investigate the patents related to memory technologies for artificial intelligence/machine learning (AI/ML) applications. Creating artificial neurons and synapses using emerging memories In recent years, neuromorphic computing has emerged as a promising technology in the post-Moore’s law era. Neuromorphic computing systems are[…]